InspireMD(NSPR)

Search documents
InspireMD(NSPR) - 2019 Q2 - Earnings Call Transcript
2019-08-07 03:00
InspireMD, Inc. (NASDAQ:NSPR) Q2 2019 Results Conference Call August 6, 2019 8:00 AM ET Company Participants Jeremy Feffer - IR Jim Barry - CEO Craig Shore - CFO Conference Call Participants Vernon Bernardino - H.C. Wainwright Operator Greetings, and welcome to the InspireMD Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being r ...
InspireMD(NSPR) - 2019 Q2 - Quarterly Report
2019-08-05 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35731 InspireMD, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employ ...
InspireMD(NSPR) - 2019 Q1 - Earnings Call Transcript
2019-05-14 17:08
InspireMD, Inc. Corp. (NASDAQ:NSPR) Q1 2019 Results Earnings Conference Call May 14, 2019 8:00 AM ET Company Participants Jeremy Feffer - IR, LifeSci Advisors, LLC Jim Barry - CEO Craig Shore - CFO Conference Call Participants Operator Greetings and welcome to the InspireMD First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is bei ...
InspireMD(NSPR) - 2019 Q1 - Quarterly Report
2019-05-13 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35731 InspireMD, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Emplo ...
InspireMD(NSPR) - 2018 Q4 - Earnings Call Transcript
2019-02-19 15:03
InspireMD, Inc. (NASDAQ:NSPR) Q4 2018 Earnings Conference Call February 19, 2019 8:00 AM ET Company Participants Jeremy Feffer - IR, LifeSci Advisors, LLC Jim Barry - CEO Craig Shore - CFO Conference Call Participants Operator Greetings and welcome to the InspireMD Fourth Quarter and Fiscal Year 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conferen ...
InspireMD(NSPR) - 2018 Q4 - Annual Report
2019-02-19 11:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-35731 InspireMD, Inc. (Exact name of registrant as specified in its charter) Delaware 26-2123838 (State or other jurisdiction of incorporation or organization) 4 M ...